• Exosomal TIE2 Delivery Drives Angiogenesis in Cervical Cance

  2026-05-27

  This article examines how tumor-derived exosomes transfer TIE2 protein to macrophages, promoting angiogenesis and progression in cervical cancer. The study reveals a direct mechanism for TEM induction, with implications for anti-angiogenic therapy and experimental workflows requiring precise protein analysis.

• Meropenem trihydrate (SKU B1217): Reliable Solutions for Lab

  2026-05-26

  This article explores how Meropenem trihydrate (SKU B1217) addresses common laboratory challenges in cell-based and resistance studies. Drawing on recent metabolomics research and real-world protocol needs, we compare its reliability, solubility, and reproducibility with alternative carbapenems, providing evidence-backed recommendations for biomedical researchers and technicians.

• Neuromedin S (rat): Protocols for GPCR Signaling and QC

  2026-05-26

  Neuromedin S (rat) provides a chemically defined peptide agonist for controlled activation of neuromedin U receptor signaling in rat-based GPCR/G protein studies. It is intended for laboratory research workflows examining physiological pathways such as energy homeostasis regulation and stress response, but is not suitable for diagnostic or therapeutic use. Researchers must follow strict handling and storage protocols to maintain assay reproducibility.

• 2X Taq PCR Master Mix: Precision PCR for Genotyping & Clonin

  2026-05-26

  APExBIO’s 2X Taq PCR Master Mix (with dye) streamlines DNA amplification with robust performance and direct-to-gel convenience. Discover how this ready-to-use master mix accelerates experimental workflows in genotyping, cloning, and translational cancer research while minimizing errors and maximizing reproducibility.

• AM251: Driving Translational Advances in CB1 Antagonist Rese

  2026-05-25

  This thought-leadership article examines the mechanistic underpinnings and translational opportunities of AM251, a potent CB1 receptor antagonist. It integrates evidence from recent cannabinoid pain research, delivers strategic guidance for complex assay design, and evaluates AM251’s distinct impact across neuropharmacology and metabolic disease models. The piece contextualizes APExBIO’s AM251 as a pivotal tool for researchers seeking precision in cannabinoid receptor research and offers practical parameters for experimental success.

• Proteoform-Specific Drug Interactions in Native Membranes

  2026-05-24

  This study pioneers the use of native top-down mass spectrometry to directly characterize proteoform-specific drug interactions in cell signaling environments. The findings reveal that post-translational modifications critically shape both target specificity and off-target effects of PDE5 inhibitors like Vardenafil, underscoring the importance of proteoform-resolved approaches in drug discovery.

• Caspase-3/7 Inhibitor I (SKU A1925): Scenario-Driven Lab Sol

  2026-05-23

  This article delivers scenario-driven, evidence-based insights for biomedical researchers using Caspase-3/7 Inhibitor I (SKU A1925) to address common challenges in apoptosis and cell viability workflows. It highlights validated use cases, protocol optimization, and comparative reliability, helping scientists make informed decisions for reproducible and sensitive caspase pathway experiments.

• Fumagillin as a Methionine Aminopeptidase-2 Inhibitor: Appli

  2026-05-22

  Fumagillin uniquely bridges cancer and aquaculture research as a potent methionine aminopeptidase-2 inhibitor. This article delivers actionable protocols, advanced troubleshooting, and data-driven insights to help researchers achieve reproducible endothelial and antiparasitic assay results using APExBIO's Fumagillin.

• Prednisone: Advanced Immunosuppression and Neurodegeneration

  2026-05-22

  Explore how Prednisone, a synthetic corticosteroid, advances immunology and neurodegeneration research through apoptosis modulation and refined assay design. This article uniquely integrates solubility strategies, protocol parameters, and cutting-edge applications beyond standard product guides.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Dual-Reporter mRNA Delivery

  2026-05-21

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) streamlines advanced mRNA delivery and translation efficiency assays with dual-fluorescence and immune-evasive modifications. Paired with state-of-the-art nanoparticle workflows and real-time tracking, it sets a new benchmark for gene regulation and functional genomics research.

• TAK-242 (Resatorvid): Reliable TLR4 Inhibition for Cell Assa

  2026-05-21

  This article provides an evidence-backed, scenario-driven guide for applying TAK-242 (Resatorvid), a selective Toll-like receptor 4 (TLR4) inhibitor (SKU A3850), to address reproducibility and workflow challenges in cell viability, proliferation, and cytotoxicity assays. By referencing quantitative literature and validated protocols, it helps bench scientists optimize inflammatory signal pathway suppression and data integrity in TLR4-related research.

• Xin Jia Congrong Tusizi Decoction Suppresses Ferroptosis to

  2026-05-20

  This study demonstrates that Xin Jia Congrong Tusizi Decoction (XJCTD) can reverse ferroptosis in granulosa cells, thereby rescuing ovarian function decline by modulating the p53/Nrf2/SLC7A11/GPX4 pathway. The findings clarify the decoction’s mechanism of action and highlight the central role of ferroptosis regulation in reproductive health.

• Preclinical Insights into Anlotinib: Selective VEGFR2 Inhibi

  2026-05-20

  This article reviews the preclinical characterization of anlotinib hydrochloride, a highly selective multi-target tyrosine kinase inhibitor with potent anti-angiogenic activity. By dissecting its mechanisms, selectivity, and efficacy in endothelial and tumor models, we explore its implications for angiogenesis-focused cancer research.

• Phenothiazines Boost Macrophage Antibacterial Activity via R

  2026-05-19

  The reference study reveals that phenothiazines significantly enhance macrophage antibacterial responses by inducing reactive oxygen species (ROS) production and autophagy, offering a host-directed alternative to conventional antibiotics. These findings clarify the molecular mechanisms behind phenothiazine-mediated immunity and suggest new therapeutic strategies for tackling antibiotic-resistant intracellular infections.

• ICG001: Wnt/β-Catenin Pathway Inhibitor for Fibrosis Researc

  2026-05-19

  ICG001 enables precise, selective modulation of Wnt/β-catenin signaling, empowering researchers to dissect CBP/β-catenin interactions in EMT-driven fibrosis and cancer models. This article details actionable workflows, troubleshooting insights, and protocol enhancements, drawing from recent advances in liver fibrosis mechanisms.

455 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page